NCT04487262

Brief Summary

Rationale: Evidence regarding the timing of chest tube removal after cardiac surgery is sparse. The timing of chest tubes removal constitutes a balancing act between risk of retained blood syndrome, infection, patient discomfort and opioid-related side effects. Several studies have shown that chest tubes can safely be removed on the first postoperative day compared to later. A single retrospective study raised concern as chest tube removal on the day of surgery was associated with an increased requirement of drainage of pleural effusions. Primary Objective: To compare the impact of two standard chest tube removal protocols following open-heart surgery on the incidence of pleural and/or pericardial effusion requiring invasive drainage Secondary Objectives To evaluate the impact of chest tube removal on the day of surgery (DAY0) compared to the first postoperative day (DAY1) regarding:

  • Comsumption of analgetic drugs
  • Early postoperative pain
  • Incidence of infection
  • Early postoperative respiratory function Study design: Single-center, open, parallel-group, prospective, cluster-randomized controlled trial Alternate assignment of chest tube removal according to Day 0 versus Day 1 protocol based upon the month of surgery (even versus odd months). Study population: 1300 consecutive patients undergoing elective open heart surgery in full or lower hemisternotomy with or without cardiopulmonary bypass including coronary artery bypass grafting, valve surgery, simple aortic surgery or combinations.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
515

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 27, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2021

Completed
Last Updated

August 8, 2023

Status Verified

August 1, 2023

Enrollment Period

1.2 years

First QC Date

July 16, 2020

Last Update Submit

August 6, 2023

Conditions

Keywords

Surgery, HeartChest TubeEffusion, PleuralComplications, PostoperativePain, Postoperative

Outcome Measures

Primary Outcomes (1)

  • Rate of postoperative pleural and/or pericardial effusion

    Effusion requiring invasive drainage

    up to 30 days after surgery

Secondary Outcomes (16)

  • Quantity of opiod consumption

    During 1st, 2nd, 3rd, and 4th postoperative day, and in total after 30 days

  • Quantity of non-steroidal anti-inflammatory drug consumption

    During 1st, 2nd, 3rd, and 4th postoperative day, and in total after 30 days

  • Intensity of postoperative pain

    Before and after first mobilization day 1

  • Amount of chest tube output

    after 24 hours and up to removal (max. up to 30 days)

  • Rate re-exploration because of bleeding

    up to 30-day follow-up

  • +11 more secondary outcomes

Study Arms (2)

Day O chest tube removal

ACTIVE COMPARATOR

Chest tubes maybe removed ten hours after arrival at the intensive care provided standardized removal criteria are fulfilled: 1. blood loss through chest tubes less than 200 ml during the last four hours 2. no air leak 3. the patient extubated and mobilized It remains at the discretion of the attending cardiac surgeon to postpone chest tube removal in cases of increased bleeding risk, due to circumstances which develop during the perioperative period

Procedure: Cardiac surgery

Day 1 chest tube removal

ACTIVE COMPARATOR

Chest tubes are removed in the early morning of the first postoperative day, provided standardized removal criteria are fulfilled: 1. blood loss through chest tubes less than 200 ml during the last four hours 2. no air leak 3. the patient extubated and mobilized It remains at the discretion of both the attending surgeon and anestesiologist to remove chest tubes prematurely in cases of drain-induced, severe analgetic resistant, intractable pain resistant to analgetic treatment.

Procedure: Cardiac surgery

Interventions

Elective open heart surgery

Day 1 chest tube removalDay O chest tube removal

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All consecutive patients undergoing elective open heart surgery in full or lower hemisternotomy with or without cardiopulmonary bypass including coronary artery bypass grafting, valve surgery, simple aortic surgery or combinations.

You may not qualify if:

  • Cardiac procedures deemed not eligible to chest tube removal on the day of surgery due to increased bleeding risk due to:
  • Procedures in hypothermic circulatory arrest
  • Previous cardiac surgery
  • Procedures performed through upper hemisternotomy
  • Emergent treatment required (\< 24 hours)
  • Non-aspirin antiplatelet drugs stopped \< 5 days preoperatively (Clopidogrel, Prasugrel, Ticagrelor, Ticlopidine)
  • Current use of vitamin K antagonists or new oral non-vitamin K anticoagulants
  • Platelet count \> 450 or \<100 x 109/l prior to surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dep. of Cardiothoracic Surgery, Aarhus University Hospital

Aarhus, 8200, Denmark

Location

Related Publications (1)

  • Andreasen JJ, Sorensen GV, Abrahamsen ER, Hansen-Nord E, Bundgaard K, Bendtsen MD, Troelsen P. Early chest tube removal following cardiac surgery is associated with pleural and/or pericardial effusions requiring invasive treatment. Eur J Cardiothorac Surg. 2016 Jan;49(1):288-92. doi: 10.1093/ejcts/ezv005. Epub 2015 Feb 7.

    PMID: 25661079BACKGROUND

MeSH Terms

Conditions

Pleural EffusionPain, PostoperativePostoperative Complications

Interventions

Cardiac Surgical Procedures

Condition Hierarchy (Ancestors)

Pleural DiseasesRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Cardiovascular Surgical ProceduresSurgical Procedures, OperativeThoracic Surgical Procedures

Study Officials

  • Ivy Susanne Modrau, MD, dr.med.

    Consultant Cardiac Surgeon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective cluster-randomized parallel study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Cardiac Surgeon, Associate Professor

Study Record Dates

First Submitted

July 16, 2020

First Posted

July 27, 2020

Study Start

September 1, 2020

Primary Completion

October 31, 2021

Study Completion

October 31, 2021

Last Updated

August 8, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will share

Individual-level deidentified patient data that support the findings of this study, and statistical analysis plan are available upon reasonable request.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Data will be available beginning immediately and ending five years after article publication.
Access Criteria
Data sharing with other researchers requires a methodologically sound proposal (detailed protocol for the proposed study, information about the funding and resources) and approval by the Danish Data Protection Agency.

Locations